TY - CONF
T1 - Prolongation effects of hemostatic ability of poly(ethyleneglycol)-modified polymerized albumin particles carrying fibrinogen-γ chain dodecapeptide (H12) as platelet substitutes
AU - Fujie, Toshinori
AU - Okamura, Yousuke
AU - Takeoka, Shinji
AU - Handa, Makoto
AU - Ikeda, Yasuo
PY - 2006/10/19
Y1 - 2006/10/19
N2 - We conjugated dodecapeptide (H12), which was a part of the amino acid sequence of fibrinogen, to the terminal of polyethyleneglycol (PEG) chains of the PEG-modified polymerized albumin particles(polyAlb), and confirmed that they showed a significant hemostatic effect even 3hrs after injection(40mg/kg) in thrombocytopenic rats.
AB - We conjugated dodecapeptide (H12), which was a part of the amino acid sequence of fibrinogen, to the terminal of polyethyleneglycol (PEG) chains of the PEG-modified polymerized albumin particles(polyAlb), and confirmed that they showed a significant hemostatic effect even 3hrs after injection(40mg/kg) in thrombocytopenic rats.
KW - Blood circulation clearance
KW - Fibrinogen γ chain dodecapeptide (H12)
KW - Hemostatic effect
KW - Platelet substitutes
KW - Polyethyleneglycol
UR - http://www.scopus.com/inward/record.url?scp=33749866343&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33749866343&partnerID=8YFLogxK
M3 - Paper
AN - SCOPUS:33749866343
T2 - 55th SPSJ Annual Meeting
Y2 - 24 May 2006 through 26 May 2006
ER -